Taiflex Scientific Co., Ltd. (TPE:8039)
47.90
+0.10 (0.21%)
Mar 14, 2025, 1:30 PM CST
Taiflex Scientific Income Statement
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
Revenue | 9,938 | 8,151 | 8,722 | 9,405 | 8,766 | Upgrade
|
Revenue Growth (YoY) | 21.93% | -6.55% | -7.26% | 7.29% | 15.59% | Upgrade
|
Cost of Revenue | 7,800 | 6,359 | 6,643 | 7,206 | 6,688 | Upgrade
|
Gross Profit | 2,138 | 1,792 | 2,079 | 2,199 | 2,079 | Upgrade
|
Selling, General & Admin | 1,052 | 934.43 | 1,024 | 931 | 762.11 | Upgrade
|
Research & Development | 394.32 | 366.52 | 400.59 | 323.22 | 281.36 | Upgrade
|
Operating Expenses | 1,475 | 1,304 | 1,431 | 1,250 | 1,036 | Upgrade
|
Operating Income | 662.72 | 487.6 | 648.08 | 948.81 | 1,043 | Upgrade
|
Interest Expense | -31.35 | -32.46 | -35.21 | -20.8 | -20.76 | Upgrade
|
Interest & Investment Income | 36.73 | 27.57 | 15.28 | 5.37 | 7.88 | Upgrade
|
Earnings From Equity Investments | -2.11 | -11.16 | -1.6 | -7.97 | -16.15 | Upgrade
|
Currency Exchange Gain (Loss) | 131.54 | -40.02 | 255.1 | -1.05 | -60.74 | Upgrade
|
Other Non Operating Income (Expenses) | -41.04 | 50.3 | -44.6 | 18.65 | 3.53 | Upgrade
|
EBT Excluding Unusual Items | 756.5 | 481.82 | 837.04 | 943.02 | 956.64 | Upgrade
|
Gain (Loss) on Sale of Investments | 4.18 | 0.81 | 39.85 | 1.61 | - | Upgrade
|
Gain (Loss) on Sale of Assets | -33.45 | -0.31 | 0.43 | -6.69 | 33.16 | Upgrade
|
Asset Writedown | -26.23 | - | - | 2.88 | -24 | Upgrade
|
Pretax Income | 701 | 482.32 | 877.31 | 940.81 | 965.8 | Upgrade
|
Income Tax Expense | 168.51 | 121.6 | 185.6 | 195.95 | 181.44 | Upgrade
|
Earnings From Continuing Operations | 532.49 | 360.72 | 691.71 | 744.86 | 784.35 | Upgrade
|
Minority Interest in Earnings | 60.29 | 62.25 | 8.77 | -10.21 | -11.49 | Upgrade
|
Net Income | 592.78 | 422.97 | 700.48 | 734.65 | 772.86 | Upgrade
|
Net Income to Common | 592.78 | 422.97 | 700.48 | 734.65 | 772.86 | Upgrade
|
Net Income Growth | 40.14% | -39.62% | -4.65% | -4.94% | 22.54% | Upgrade
|
Shares Outstanding (Basic) | 235 | 219 | 219 | 219 | 219 | Upgrade
|
Shares Outstanding (Diluted) | 259 | 263 | 261 | 258 | 220 | Upgrade
|
Shares Change (YoY) | -1.43% | 0.83% | 0.92% | 17.36% | 0.02% | Upgrade
|
EPS (Basic) | 2.53 | 1.93 | 3.20 | 3.36 | 3.53 | Upgrade
|
EPS (Diluted) | 2.32 | 1.66 | 2.74 | 2.85 | 3.51 | Upgrade
|
EPS Growth | 39.46% | -39.31% | -3.74% | -18.84% | 22.34% | Upgrade
|
Free Cash Flow | 727.6 | 256.7 | 164.64 | -301.13 | 581.99 | Upgrade
|
Free Cash Flow Per Share | 2.81 | 0.98 | 0.63 | -1.17 | 2.64 | Upgrade
|
Dividend Per Share | 2.500 | 0.879 | 2.390 | 2.390 | 2.390 | Upgrade
|
Dividend Growth | 184.35% | -63.21% | 0% | 0% | 0% | Upgrade
|
Gross Margin | 21.51% | 21.98% | 23.84% | 23.38% | 23.71% | Upgrade
|
Operating Margin | 6.67% | 5.98% | 7.43% | 10.09% | 11.90% | Upgrade
|
Profit Margin | 5.96% | 5.19% | 8.03% | 7.81% | 8.82% | Upgrade
|
Free Cash Flow Margin | 7.32% | 3.15% | 1.89% | -3.20% | 6.64% | Upgrade
|
EBITDA | 1,142 | 896.01 | 1,035 | 1,302 | 1,336 | Upgrade
|
EBITDA Margin | 11.49% | 10.99% | 11.87% | 13.84% | 15.24% | Upgrade
|
D&A For EBITDA | 478.96 | 408.41 | 386.8 | 353.15 | 293.39 | Upgrade
|
EBIT | 662.72 | 487.6 | 648.08 | 948.81 | 1,043 | Upgrade
|
EBIT Margin | 6.67% | 5.98% | 7.43% | 10.09% | 11.90% | Upgrade
|
Effective Tax Rate | 24.04% | 25.21% | 21.16% | 20.83% | 18.79% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.